Vimta Labs Limited has signed a Business Transfer Agreement to sell its Clinical Diagnostics Business Division to Thyrocare Technologies for a total revenue of INR 30 Crores in FY 2024 and INR 7 Crores in Q1 FY 2025, aiming to enhance Thyrocares mark
AI Assistant
Vimta Labs Ltd
2024
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.